Literature DB >> 12208130

The phenylketonuria mouse model: a meeting review.

J David McDonald1, Maria Andriolo, Francesco Calì, Mario Mirisola, Stefano Puglisi-Allegra, Valentino Romano, Christineh N Sarkissian, Carolyn B Smith.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2002        PMID： 12208130     DOI： 10.1016/s1096-7192(02)00115-4

Source DB:  PubMed          Journal:  Mol Genet Metab        ISSN： 1096-7192            Impact factor:   4.797


× No keyword cloud information.
  6 in total

1.  Advances and challenges in phenylketonuria.

Authors:  Cary O Harding; Nenad Blau
Journal:  J Inherit Metab Dis       Date:  2010-12       Impact factor: 4.982

2.  Characterization of 2-(methylamino)alkanoic acid capacity to restrict blood-brain phenylalanine transport in Pah enu2 mice: preliminary findings.

Authors:  Kara R Vogel; Erland Arning; Brandi L Wasek; Teodoro Bottiglieri; K Michael Gibson
Journal:  Mol Genet Metab       Date:  2013-08-15       Impact factor: 4.797

Review 3.  State-of-the-art 2003 on PKU gene therapy.

Authors:  Zhaobing Ding; Cary O Harding; Beat Thöny
Journal:  Mol Genet Metab       Date:  2004-01       Impact factor: 4.797

4.  Differences in postingestive metabolism of glutamate and glycine between C57BL/6ByJ and 129P3/J mice.

Authors:  Hong Ji; Alexander A Bachmanov
Journal:  Physiol Genomics       Date:  2007-09-25       Impact factor: 3.107

5.  Biochemical, Metabolic, and Behavioral Characteristics of Immature Chronic Hyperphenylalanemic Rats.

Authors:  Gerald A Dienel; Nancy F Cruz
Journal:  Neurochem Res       Date:  2015-07-30       Impact factor: 3.996

6.  Protective effect of recombinant adeno-associated virus 2/8-mediated gene therapy from the maternal hyperphenylalaninemia in offsprings of a mouse model of phenylketonuria.

Authors:  Sung-Chul Jung; Joo-Won Park; Hyun-Jeong Oh; Jin-Ok Choi; Kyung-In Seo; Eun-Sook Park; Hae-Young Park
Journal:  J Korean Med Sci       Date:  2008-10       Impact factor: 2.153
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.